STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Deerfield's 15.36M-Share (6.47%) Passive Stake in BKDT Disclosed

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Deerfield Mgmt, L.P. and affiliated entities reported beneficial ownership of 15,362,264 shares of Brookdale Senior Living common stock, representing 6.47% of the class, in Amendment No. 3 to a Schedule 13G/A. The filing is submitted under Rule 13d-1(b), indicating a passive reporting status. All reporting persons disclose 0 sole voting and dispositive power and 15,362,264 shares of shared voting and dispositive power. The statement includes a certification that the securities were not acquired to change or influence control. The filing was signed by Jonathan Isler as Attorney-in-Fact on 08/14/2025 and cites an event date of 06/30/2025.

Positive

  • Material disclosure: Reporting persons beneficially own 15,362,264 shares, representing 6.47% of Brookdale Senior Living common stock.
  • Passive filing: Position reported under Rule 13d-1(b) on a Schedule 13G/A, indicating the stake is disclosed as passive.

Negative

  • None.

Insights

Deerfield reports a material, passive 6.47% stake (15.36M shares) via Schedule 13G/A.

The filing discloses that Deerfield Mgmt, Deerfield Management Company, Deerfield Partners and James E. Flynn each beneficially own 15,362,264 shares, equal to 6.47% of the outstanding common stock. The position is reported under Rule 13d-1(b), which denotes a passive stake rather than an activist intent. Reported powers show 0 sole voting or dispositive authority and full shared voting and dispositive power over the disclosed shares, providing clear attribution of control among the filing parties.

Schedule 13G/A indicates passive joint ownership with shared voting/dispositive power and includes certification against control-seeking.

The joint filing structure and exhibits (Joint Filing Agreement, Item 8 statement, Power of Attorney) demonstrate coordinated disclosure by Deerfield entities and James E. Flynn. The certification in Item 10 explicitly states the holdings were not acquired to influence control. Signatures executed by an Attorney-in-Fact (Jonathan Isler) are included with dates, and the filing identifies Delaware-organized reporting entities and the filer’s New York address, satisfying formal disclosure and attribution requirements.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of common stock held by Deerfield Partners, L.P., of which Deerfield Mgmt, L.P. is the general partner.


SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of common stock held by Deerfield Partners, L.P., of which Deerfield Management Company, L.P. is the investment advisor.


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Comprised of shares of common stock held by Deerfield Partners, L.P.


SCHEDULE 13G



Deerfield Mgmt, L.P.
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:08/14/2025
Deerfield Management Company, L.P.
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:08/14/2025
Deerfield Partners, L.P.
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:08/14/2025
James E. Flynn
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:08/14/2025
Exhibit Information

Exhibit A. Joint Filing Agreement. Exhibit B. Item 8 Statement. Exhibit C. Power of Attorney (1). (1) Power of Attorney previously filed as Exhibit 24 to a Form 3 with regard to BiomX Inc. filed with the Securities and Exchange Commission on March 19, 2024 by Deerfield Private Design Fund V, L.P., Deerfield Healthcare Innovations Fund II, L.P., Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P., Deerfield Management Company, L.P. and James E. Flynn.

FAQ

What stake did Deerfield report in Brookdale Senior Living (BKDT)?

15,362,264 shares, representing 6.47% of the outstanding common stock.

Under which rule was the Schedule 13G/A filed for BKDT?

The filing is checked under Rule 13d-1(b), indicating a passive investor disclosure.

Do the reporting persons have sole voting or dispositive power over these shares?

No. The filing reports 0 shares with sole voting or dispositive power and 15,362,264 shares with shared voting and dispositive power.

What dates are associated with the filing and signatures?

The event date requiring the filing is 06/30/2025; signatures are dated 08/14/2025.

Who signed the Schedule 13G/A on behalf of Deerfield and affiliates?

Jonathan Isler, Attorney-in-Fact, signed on behalf of Deerfield Mgmt, Deerfield Management Company, Deerfield Partners, L.P. and James E. Flynn.
Brookdale Senior

NYSE:BKDT

BKDT Rankings

BKDT Latest News

BKDT Latest SEC Filings

BKDT Stock Data

2.88M
Services-nursing & Personal Care Facilities
BRENTWOOD